Clinical trial
Glutamate for Metabolic Intervention in Coronary Surgery
NCT00489827 · University Hospital, Linkoeping, Other · Completed
Key facts
| NCT number | NCT00489827 |
|---|---|
| Title | Glutamate for Metabolic Intervention in Coronary Surgery |
| Official title | Phase III Study of Intravenous Glutamate Infusion for Metabolic Protection of the Heart in Surgery for Unstable Coronary Artery Disease |
| Acronym | GLUTAMICS |
| Lead sponsor | University Hospital, Linkoeping, Other |
| Collaborators | Region Örebro County Blekingesjukhuset, Karlskrona |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Bypass, Myocardial Ischemia, Myocardial Infarction, Coronary Artery Disease |
| Intervention type | Drug, Other |
| Interventions | Intravenous infusion of saline, Intravenous glutamate infusion |
| Enrollment | 865 |
| Start date | Oct 1, 2005 |
| Primary completion | Dec 1, 2009 |
| Completion | Aug 1, 2022 |
| First posted | Jun 21, 2007 |
| Last update posted | May 22, 2024 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: